Showing results (91-100 of 190) with videos related to
Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced MalignanciesJason J Luke, Sarina A Piha-Paul, Theresa Medina, et al.Journal for Immunotherapy of Cancer|February 11, 2026
Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumorsJohn L Villano, Jason J Luke, Ricklie Julian, et al.Journal of Translational Medicine|November 27, 2019
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinomaBrian W Labadie, Ping Liu, Riyue Bao, et al.Journal for Immunotherapy of Cancer|May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trialJason J Luke, Katherine Bever, F Stephen Hodi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or LymphomasJason J Luke, Randy F Sweis, J Randolph Hecht, et al.International Journal of Radiation Oncology, Biology, Physics|June 26, 2022
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and ImmunotherapyMark C Korpics, Rohan R Katipally, Julien Partouche, et al.Journal for Immunotherapy of Cancer|October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case seriesSowmya Ravi, Kristen Spencer, Mary Ruisi, et al.JAMA Network Open|February 17, 2026
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical TrialSancy A Leachman, Jason J Luke, Paolo A Ascierto, et al.Cancer Immunology Research|April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma PatientsMarlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Multiregional CT Features Improve Prediction of Immunotherapy Response in Advanced MelanomaGrant Kokenberger, Jatin Singh, Drew Hurd, et al.Pageof 19